Company / Working Capital
Vera Therapeutics, Inc. Working Capital History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$675.4M
FY2025
5-year range
$74.8M / $675.4M
FY2021-FY2025
Trend
+7.9%
vs FY2024
Sector context
#65 of 213
Health Care
What the data says
At $675M, Vera Therapeutics, Inc.'s working capital ranks #65 of 213 in the Health Care sector. Working Capital has increased for 5 consecutive years, from $52M in FY2020 to $675M in FY2025.
Based on SEC 10-K filings.
$675M in FY2025 with a 5-year CAGR of +67.1%.
Improved from $150M to $675M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +89.0%
- 5-Year CAGR
- +67.1%
- 10-Year CAGR
- -
Sector benchmark
#65 of 213 in Health CareTop 31% of 213This company $675.4M Sector average $934.6M
▼
-27.7% below sector average
Key checks
Key Insights
- Vera Therapeutics, Inc.'s working capital has grown for 5 consecutive years.
- 5-year CAGR of +67.1%, indicating consistent growth.
- In FY2025, working capital increased 7.9% year-over-year.
- Ranks #65 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $675.4M | +7.9% |
| FY2024 | $625.8M | +318.0% |
| FY2023 | $149.7M | +49.6% |
| FY2022 | $100.1M | +33.7% |
| FY2021 | $74.8M | +44.3% |
| FY2020 | $51.9M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026